To test whether our gene therapy approach could revert the myopathy phenotype after disease onset, retro‐orbital injections were performed in symptomatic smKO mice (2‐month‐old) with either rAAV9‐Ndufs3 or rAAV9‐eGFP. This evidence concerns the gene NDUFS3 and myopathy.